TardiMed Sciences LLC, 10% Owner at Timber Pharmaceuticals, Inc. (TMBR), sold 300,000 shares at $0.92 ($276K) on 2021-08-26, disclosed to the SEC on 2021-08-26.
Open-market sale of $276k TMBR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.93 | 100,000 | $93K | 33.7% |
| 2 | $0.91 | 100,000 | $91K | 33.0% |
| 3 | $0.92 | 100,000 | $92K | 33.3% |
| Total | $0.92 avg | 300,000 | $276K | 100% |
| Filing → |
| TMBR | SELL | 2021-09-01 | $368K | — | Filing → |
| TMBR | SELL | 2021-08-20 | $168K | — | Filing → |
| TMBR | SELL | 2021-06-15 | $408K | — | Filing → |